ACUTE - PowerPoint PPT Presentation

About This Presentation
Title:

ACUTE

Description:

ACUTE & CHRONIC KIDNEY FAILURE By Maritza I. Garcia-Duran & Joao Mc-O neil Internal Medicine 06/21/2010 TREATMENT There is no specific treatment unequivocally shown ... – PowerPoint PPT presentation

Number of Views:250
Avg rating:3.0/5.0
Slides: 44
Provided by: A0009
Category:

less

Transcript and Presenter's Notes

Title: ACUTE


1
ACUTE CHRONIC KIDNEY FAILURE
  • By Maritza I. Garcia-Duran Joao Mc-Oneil
  • Internal Medicine
  • 06/21/2010

2
(No Transcript)
3
ACUTE KINEY FAILURE a.k.a. Acute Kidney Injury
(AKI)
  • rapid loss of kidney function
  • REVERSIBLE

4
(No Transcript)
5
CAUSES
6
(No Transcript)
7
(No Transcript)
8
Other Signs and Symptoms of AKI
  • f/b generalized swelling, d/t waste products
    build in the blood.
  • Met. Acidosis
  • Arrhythmias d/t hyperkalemia. Including v-tach
    and v-fib
  • Encephalopathy altered thinking and
    pericarditis d/t uremia and low serum calcium
  • Anemia d/t decreased EPO production
  • Hypertension d/t inc fluid deposited in lung
    causing CHF
  • Tachypnea

9
(No Transcript)
10
DIAGNOSIS
  • Rapid time course (less than 48 hours)
  • Reduction of kidney function
  • Rise in serum creatinine
  • Absolute increase in serum creatinine of
    0.3 mg/dl
  • Percentage increase in serum creatinine of 50
  • Reduction in urine output, defined as lt0.5
    ml/kg/hr for more than 6 hours (about 210mL in 6
    hours)

11
HUMAN REFERENCE RANGE OF SERUM CREATININE
  • 0.5 to 1.0 mg/dL (about 45-90 µmol/L) for women
  • 0.7 to 1.2 mg/dL (60-110 µmol/L) for men.
  • While a baseline serum creatinine of 2.0 mg/dL
    (150 µmol/L) may indicate normal kidney function
    in a male body builder, a serum creatinine of
    1.2 mg/dL (110 µmol/L) can indicate significant
    renal disease in an elderly female

12
(No Transcript)
13
MANAGEMENT
  1. treatment of the underlying cause
  2. avoid nephrotoxins (antibiotics,
    chemotherapeautics, contrast dye, PCN,
    Aminoglycosides, ACEI, NSAIDS, etc.)
  3. Monitoring of renal function, by serial serum
    creatinine measurements and
  4. monitoring of urine output
  5. urinary catheter helps monitor urine output and
    relieves possible bladder outlet obstruction,
    such as with an enlarged prostate

14
(No Transcript)
15
  • Specific therapies
  • intravenous fluids is typically the first step to
    improve renal function.
  • Volume status may be monitored with the use of a
    central venous catheter to avoid over- or
    under-replacement of fluid.
  • inotropes such as norepinephrine and dobutamine
    to improve cardiac output and renal perfusion.
  • Dopamine may be harmful.
  • Diuretic agents like furosemide
  • Renal replacement therapy like hemodialysis

16
COMPLICATIONS
  • Metabolic acidosis
  • Hyperkalemia
  • pulmonary edema
  • end-stage renal failure requiring lifelong
    dialysis or a kidney transplant.

17
QUESTION
  • For each of the following questions, choose the
    pathophysiologic mechanism of reduced glomerular
    filtration rate (GFR).
  • Acute tubular necrosis
  • Decreased relaxation of afferent arterioles
  • Glomerulonephritis
  • Hypovolemia
  • Increased relaxation of efferent arterioles

18
Question 1
  • A 55 yo male has a history of HTN and MI. He is
    seen in the clinic to follow up on his blood
    pressure. There are no sxs. The patients
    current medical regimen includes amlodipine,
    hydrochlorothiazide, and atenolol. Blood
    pressure is measured at 165/83 in both arms. The
    remainder of the physical examination is notable
    for an abdominal bruit. Lisinopril is added to
    the regimen. One week later blood work shows a
    creatinine that has risen from 1.3mg/dL to 5.0
    mg/KL

19
Answer E Increased RELAXATION OF THE EFFERENT
ARTERIOLES
  • Decreased renal perfusion, or pre-renal failure,
    is a common cause of renal failure and is often
    rapidly reversible. GFR is manteined at a
    constant state by PG ? relax Afferent arteriole,
    and Ang II ? contract Efferent arteriole (EA).
  • An ACEI (Lisinopril) ? decrease Ang II ? increase
    relaxation of EA ? decrease GFR ? increase
    creatinine.

20
Question 2
  • An 88-year-old female is admitted to the hospital
    after being found in her apartment with altered
    mental status by family members. Physical
    examination is notable for delirium, poor skin
    turgor and dry MM. BUN is 63mg/dL, and
    creatinine is 1.3 mg/dL.

21
ANSWER D , HYPOVOLEMIA
  • Classic presentation of dehydration with poor
    skin turgor and dry MM. In light of her advance
    age, a creatinine of 1.3 mg/dL reflects very poor
    renal functon.

22
Chronic kidney disease (CKD), also known as
chronic renal disease
23
progressive loss of renal function over a period
of months or years. IRREVERSIBLE
24
  • Causes
  • diabetic nephropathy,
  • hypertension
  • glomerulonephritis.
  • HIV nephropathy.
  • PCKD

25
CLASSIFICATION
  • Vascular-renal artery stenosis -ischemic
    nephropathy, hemolytic-uremic syndrome and
    vasculitis
  • Glomerular-focal segmental glomerulosclerosis and
    IgA nephritis
  • diabetic nephropathy and lupus nephritis
  • Tubulointerstitial including polycystic kidney
    disease, drug and toxin-induced chronic
    tubulointerstitial nephritis and reflux
    nephropathy
  • Obstructive such as with bilateral kidney stones
    and diseases of the prostate
  • On rare cases, pin worms infecting the kidney can
    also cause idiopathic nephropathy.

26
(No Transcript)
27
  • Signs and symptoms
  • increase in serum creatinine or protein in the
    urine
  • hypertension and/or suffering from congestive
    heart failure
  • Urea accumulates, leading to azotemia and
    ultimately uremia (symptoms ranging from lethargy
    to pericarditis and encephalopathy).
  • Urea is excreted by sweating and crystallizes on
    skin ("uremic frost").

28
  • Hyperkalemia symptoms malaise and potentially
    fatal cardiac arrhythmias
  • Erythropoietin decreased anemia, which causes
    fatigue
  • Fluid volume overload - mild edema to
    life-threatening pulmonary edema
  • Hyperphosphatemia - due to reduced phosphate
    excretion
  • hypocalcemia (due to vitamin D3 deficiency)-
    tetany.--progresses to tertiary
    hyperparathyroidism, with hypercalcaemia, renal
    osteodystrophy and vascular calcification that
    further impairs cardiac function.

29
  • Metabolic acidosis, due to accumulation of
    sulfates, phosphates, uric acid etc. This may
    cause altered enzyme activity by excess acid
    acting on enzymes and also increased excitability
    of cardiac and neuronal membranes by the
    promotion of hyperkalemia due to excess acid
    (acidemia)
  • accelerated atherosclerosis
  • Cardiovascular disease-worse prognosis

30
DIAGNOSIS
  • It is important to differentiate CKD from acute
    renal failure (ARF) because ARF can be
    reversible.
  • gradual rise in serum creatinine (over several
    months or years) as opposed to a sudden increase
    in the serum creatinine (several days to weeks).
  • Abdominal ultrasound CKD KIDNEYS ARE SMALLER THAN
    NL (LESS THAN 9CM), except in DM nephropathy or
    PCKD
  • nuclear medicine MAG3 scan to confirm blood flows
    and establish the differential function between
    the two kidneys. DMSA scans are also used in
    renal imaging with both MAG3 and DMSA being used
    chelated with the radioactive element
    Technetium-99.

31
PCKD-CKD
32
(No Transcript)
33
(No Transcript)
34
TREATMENT
  • There is no specific treatment unequivocally
    shown to slow the worsening of chronic kidney
    disease.
  • If there is an underlying cause to CKD, such as
    vasculitis, this may be treated directly with
    treatments aimed to slow the damage.
  • In more advanced stages, treatments may be
    required for anemia and bone disease.
  • Severe CKD requires one of the forms of renal
    replacement therapy this may be a form of
    dialysis, but ideally constitutes a
  • kidney transplant.1

35
(No Transcript)
36
(No Transcript)
37
TREATMENT
  • The goal of therapy is to slow down or halt the
    otherwise relentless progression of CKD to stage
    5.
  • Control of blood pressure (ACEIS, OR ARBs) as
    they have been found to slow the progression of
    CKD to stage 5
  • erythropoietin and vitamin D3, calcium.
  • Phosphate
  • stage 5 CKD, renal replacement therapy is
    required, in the form of either dialysis or a
    transplant.
  • dietary modifications includes limiting protein
    intake.

38
(No Transcript)
39
QUESTION 1
A 57 yearold man is on maintenance hemodialysis
for chronic renal failure. Which of the following
metabolic derangement can be anticipated
  1. Hypercalcemia
  2. Hypophosphatemia
  3. Osteomalacia
  4. Vitamin D excess
  5. Hypoparathyroidism

40
Answer
  • C. Osteomalacia
  • Chronic renal failure treated with hemodialysis
    results in predictable metabolic abnormalities.
    The kidneys fail to excrete phosphate, leading to
    hyperphosphatemia and fail to excrete phosphate,
    leading to hyperphosphatemia, and fail to
    syntehsize 1,25 (OH)2D3. Vitamin D deficiency
    causes impaired interstitial calcium absorption.
    Phosphate retention, defective intestinal
    absorption, and skeletal resistance to
    parathyroid hormone all results in hypocalcemia.
    Hypocalcemia causes secondary hyperparathyroidism,
    and the excess PTH production worsens the
    hyperphosphatemia by increasing phosphorus
    release from bone. These derangements impair
    collagen synthesis and maturation, resulting in
    skeletal abnormalities collectively reffered to
    as renal osteodystrophy. Osteomalacia,
    osteosclerosis, and osteitis fribrosa cystica may
    all be seen. (Kasper et al., 2005, pp. 1656-1657).

41
QUESTION 2
  • A 60 year old patient with long-standing
    diabestes has a creatinine of 3.6 which has been
    stable for several years. Which of the following
    antibiotics requires the most dosage modification
    in chronic renal failure?
  • Tetracycline.
  • Gentamicin
  • Erythromycin
  • Nafcillin
  • Choramphenicol.

42
ANSWER
  • B. Gentamicin
  • Many drug require dosage modifications in chronic
    renal insufficiency. Bioavailability,
    distribution, action, and elimination of drugs
    all may altered. Drug that are nephrotoxic may be
    contraindicated or used only with extreme care in
    renal insuficiency. The amino-glycosides,
    vancomycin, ampicillin, most cephalosporins,
    methicillin, penicillin G, sulfonamides, and
    trimethoprim all should be given in reduced
    dosage to patients with chronic renal failure.
    The aminoglycosides and vancomycin can be
    nephrotoxic and should be used with caution in
    renal insufficiency. The small group of
    antibiotics not needing dosage modification
    includes chloramphenicol, erythromycin, the
    isoxazolyl penicillins (nafcilllin and oxacillin)
    and moxifloxacin. (Kasper et al., 2005, p. 1662,
    19).

43
  • What is man but an ingenious machine designed to
    turn with infinite artfulness, the red wine of
    shiraz into urine !
  • Isak Denison
Write a Comment
User Comments (0)
About PowerShow.com